ESC 365 - Atherothrombotic risk and outcomes following guided de-escalation of antiplatelet treatment in patients with acute coronary syndrome:a post-hoc analysis of the TROPICAL-ACS trial

ESC Premium Access

Atherothrombotic risk and outcomes following guided de-escalation of antiplatelet treatment in patients with acute coronary syndrome:a post-hoc analysis of the TROPICAL-ACS trial

Session: Antithrombotic therapy for coronary artery disease: opportunities and challenges

Topic: Pharmacotherapy

Speaker: Professor K. Rizas (Munich, DE)

Event: ESC Congress 2019

Congress Presentation

Add to my library

About the speaker

Professor Konstantinos D Rizas

Ludwig Maximilians University, Munich (Germany)

0 follower

3 more presentations in this session

State of the Art - New options in antithrombotic therapy for coronary artery disease

Speaker: Professor K. Newby (Durham, US)

Frequency, management and outcomes of patients with stable coronary artery disease eligible for COMPASS. An analysis of the CLARIFY registry.

Speaker: Doctor E. Sorbets (Paris, FR)

Secondary prevention in 2030: will antiplatelets or anticoagulants prevail?

Speaker: Professor D. Angiolillo (Jacksonville, US)

Access the full session

Antithrombotic therapy for coronary artery disease: opportunities and challenges

Speakers: Professor K. Rizas, Professor K. Newby, Doctor E. Sorbets, Professor D. Angiolillo

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources